Kyverna Therapeutics, Inc. (KYTX)
8.65
-0.51
(-5.57%)
USD |
NASDAQ |
Jan 15, 12:53
Kyverna Therapeutics Shareholders Equity (Quarterly): 151.95M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 505.82M |
| CorMedix, Inc. | 374.13M |
| Castle Biosciences, Inc. | 467.05M |
| Vistagen Therapeutics, Inc. | 66.34M |
| Ocugen, Inc. | 3.533M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 187.16M |
| Total Liabilities (Quarterly) | 35.21M |
| Debt to Equity Ratio | 0.0331 |
| Current Ratio | 5.164 |
| Net Debt Paydown Yield | 0.38% |